SEC Filing Details
Document Details
Form
Filing Date
Sep 7, 2017
Document Date
Sep 5, 2017
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
CRISPR Therapeutics
Issuer
CRISPR Therapeutics AG
Filer
Versant Venture Capital V (Canada), LP